|
|
Other links at Articles > Dermatology |
| 1. |
Sorafenib Plus Dacarbazine Shows Promise in Advanced Melanoma
|
|
|
In a phase II study of chemotherapy-naive patients with stage III (unresectable) or stage IV melanoma, the addition of the Raf kinase inhibitor sorafenib to dacarbazine yielded an "encouraging" improvement in progression-free survival, the primary endpoint, and was well tolerated, researchers report. Reuters Health Information
|
| 3. |
Infliximab Improves Psoriatic Nail Disease
|
|
|
Infliximab is highly effective for treatment of psoriatic nail disease, according to a post-hoc analysis of the European Infliximab for Psoriasis (Remicade) Efficacy and Safety Study. Reuters Health Information
|
|
|
